Mobile

Safety and Efficacy of turoctocog alfa pegol (N8-GP) in Previously Untreated Patients with Haemophilia A Evaluar la inmunogenia inmunogenicidad de N8-GP (turoctocog alfa pegol) en pacientes no ...

Update Il y a 4 ans
Reference: U1111-1148-1897

Safety and Efficacy of turoctocog alfa pegol (N8-GP) in Previously Untreated Patients with Haemophilia A Evaluar la inmunogenia inmunogenicidad de N8-GP (turoctocog alfa pegol) en pacientes no tratados previamente con hemofilia A grave

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate immunogenicity of N8-GP (turoctocog alfa pegol) in previously untreated patients (PUPs) with severe haemophilia A Evaluar la inmunogeneicidad de N8-GP (turoctocog alfa pegol) en pacientes no tratados previamente (PNTP)con hemofilia A grave

Inclusion criteria

  • Haemophilia A,Hemofilia A

Links